Comment on "Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease"

[Extract] We read with great interest the recent article by Hsieh et al. evaluating the association between Mediterranean diet (MED) adherence and the liver fibrosis risk among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) [1]. The authors reported that higher adherence to the alternate Mediterranean diet (aMED) is independently associated with reduced risk of liver fibrosis, especially among individuals with a greater cardiometabolic risk factor burden.

Journal of Gastroenterology and Hepatology

Journal of Gastroenterology and Hepatology

41

1440-1746

N/A

7

2